Compare InMode Ltd (INMD) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Nucor Corporation — how do they compare? InMode Ltd trades at $14.22 (market cap $809.93M), while Nucor Corporation trades at $250.23 (market cap $55.84B). The key difference: Nucor Corporation is far larger — about 68.9× InMode Ltd's market cap, and Nucor Corporation pays a 0.91% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Nucor Corporation for 78 Days on average.
| INMD | NUE | |
|---|---|---|
Market Cap | $809.93M | $55.84B |
Volume | 365,490 | 848,835 |
Sector | Health | Basic Materials |
52-Week High | $16.62 | $274.74 |
52-Week Low | $12.76 | $131.78 |
Typical Hold Time | 28 Days | 78 Days |
Enterprise Value | $313.27M | $60.25B |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
Nucor (NUE) trades at $250.33, up 1.58% with a mixed technical picture showing bearish moving averages but neutral oscillators. The company delivered strong Q2 2026 earnings of $4.84 EPS, beating expectations, and projects higher Q3 earnings on improved steel pricing. Revenue has stabilized at $32.49B in 2025 after declines from 2022 peaks, with net margins improving to 7.99%. Analyst consensus remains positive with a $266.88 price target and 57.58% buy ratings.
Nucor presents a balanced opportunity with strong operational performance and shareholder returns through dividends, though facing headwinds from competitive pressures and cyclical steel demand. The stock's valuation appears reasonable with P/E of 19.64 and P/S of 1.56, but investors should monitor execution against Q3 guidance and industry capacity expansions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
